GR. Sarantis S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3874
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ギリシャ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GR. Sarantis S.A. – Strategy, SWOT and Corporate Finance Report
Summary

GR. Sarantis S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GR. Sarantis S.A. (Sarantis or ‘the group’) manufactures and markets cosmetics and household products. It also provides mass market cosmetics, that include skin care products, fragrances and toiletries, hair care products, sun care products, baby shampoos; and household products that include home care, food care, shoe care, insect control, and professional products. It also provides health care products comprising of food supplements, personal hygiene and care products and luxury cosmetics. The company distributes its products through beauty shops, supermarkets, pharmacies; and exports products to several countries. The group primarily operates in Europe. Sarantis is headquartered in Athens, Greece.

Scope

- Detailed information on GR. Sarantis S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GR. Sarantis S.A. in the form of a SWOT analysis
- An in-depth view of the business model of GR. Sarantis S.A. including a breakdown and examination of key business segments
- Intelligence on GR. Sarantis S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GR. Sarantis S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GR. Sarantis S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GR. Sarantis S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GR. Sarantis S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
GR. Sarantis S.A.: Company Overview 7
GR. Sarantis S.A.: Overview and Key Facts 7
GR. Sarantis S.A.: Overview 7
GR. Sarantis S.A.: Key Facts 7
GR. Sarantis S.A.: Key Employees 9
GR. Sarantis S.A.: Key Employee Biographies 10
GR. Sarantis S.A.: Major Products and Services 12
GR. Sarantis S.A.: Company History 14
GR. Sarantis S.A.: Locations and Subsidiaries 18
GR. Sarantis S.A.: Key Competitors 19
GR. Sarantis S.A.: Company Analysis 20
GR. Sarantis S.A.: Business Description 20
GR. Sarantis S.A.: SWOT Analysis 21
GR. Sarantis S.A.: SWOT Overview 21
GR. Sarantis S.A.: Strengths 21
GR. Sarantis S.A.: Weaknesses 22
GR. Sarantis S.A.: Opportunities 22
GR. Sarantis S.A.: Threats 23
GR. Sarantis S.A.: Corporate Financial Deals Activity 24
GR. Sarantis S.A.: Financial Deals Overview 24
GR. Sarantis S.A.: Targets and Partners 25
GR. Sarantis S.A.: Top Deals 2014 – 2018YTD* 26
GR. Sarantis S.A.: Mergers and Acquisitions 27
GR. Sarantis S.A.: Recent Developments 28
GR. Sarantis S.A.: News and Events Summary 28
GR. Sarantis S.A.: Financial Performance 28
Appendix 29
Contact Us 29
Methodology 29
About MarketLine 30

List of Tables
Table 1: GR. Sarantis S.A.: Key Facts
Table 2: GR. Sarantis S.A.: Key Employees
Table 3: GR. Sarantis S.A.: Locations and Subsidiaries
Table 4: GR. Sarantis S.A.: Key Competitors
Table 5: GR. Sarantis S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: GR. Sarantis S.A.: M&A Average Deal Size - Value (US$m)
Table 7: GR. Sarantis S.A.: Targets and Partners
Table 8: GR. Sarantis S.A.: Top Deals 2014 - 2018YTD*
Table 9: GR. Sarantis S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: GR. Sarantis S.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 11: GR. Sarantis S.A.: News and Events Summary
Table 12: GR. Sarantis S.A.: Financial Performance

List of Figures
Figure 1: GR. Sarantis S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: GR. Sarantis S.A.: M&A Average Deal Size - Value (US$m)
Figure 3: GR. Sarantis S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: GR. Sarantis S.A.: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[GR. Sarantis S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • GENEWIZ Inc:医療機器:M&Aディール及び事業提携情報
    Summary GENEWIZ Inc (GENEWIZ) is a provider of genomics and technical support services. The company’s services comprise next generation sequencing, sanger sequencing, gene synthesis, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, oligo synthesis services and GLP-compliant serv …
  • Group Five Limited (GRF):企業の財務・戦略的SWOT分析
    Group Five Limited (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …
  • Reliance General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pan Pacific Hotels Group Ltd:企業の戦略・SWOT・財務分析
    Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Sanjiu Medical & Pharmaceutical Co Ltd (Sanjiu) a subsidiary of China Resources (Holdings) Co., Ltd. researches and develops, manufactures and commercializes pharmaceutical products including traditional Chinese medicine OTC and prescription drugs. Sanjiu’s product portfolio …
  • Ameren Corporation (AEE):電力:M&Aディール及び事業提携情報
    Summary Ameren Corporation (Ameren) is a public utility holding company that generates, transmits and distributes electricity; and transmits and distributes natural gas through its subsidiaries. The company generates electricity through varied energy sources such as coal, nuclear, hydro, solar, natu …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務情報
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mechanics Bank:企業の戦略・SWOT・財務情報
    Mechanics Bank - Strategy, SWOT and Corporate Finance Report Summary Mechanics Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sunquest Information Systems, Inc.-医療機器分野:企業M&A・提携分析
    Summary Sunquest Information Systems, Inc. (Sunquest), a subsidiary of Roper Industries, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory information system that au …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Chang Chun Petrochemical Co Ltd:企業の戦略的SWOT分析
    Chang Chun Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The Bank of New York Mellon Corporation:企業のM&A・事業提携・投資動向
    The Bank of New York Mellon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of New York Mellon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Zargon Oil & Gas Ltd (ZAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Zargon Oil & Gas Ltd (Zargon) is an upstream energy company. It carries out the exploration, development and production of oil and natural gas. The company’s core business is oil exploitation in the Western Canadian and Williston sedimentary basins. The company also specializes in all three …
  • ValiRx Plc (VAL):医療機器:M&Aディール及び事業提携情報
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆